- Home
- HSDT vs YCBD Comparison
HSDT vs YCBD Comparison
Compare HSDT & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- YCBD
- Stock Information
- Founded
- HSDT 2014
- YCBD 2015
- Country
- HSDT United States
- YCBD United States
- Employees
- HSDT N/A
- YCBD N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- HSDT Health Care
- YCBD Health Care
- Exchange
- HSDT Nasdaq
- YCBD Nasdaq
- Market Cap
- HSDT 1.8M
- YCBD 1.9M
- IPO Year
- HSDT N/A
- YCBD N/A
- Fundamental
- Price
- HSDT $0.47
- YCBD $0.46
- Analyst Decision
- HSDT Buy
- YCBD
- Analyst Count
- HSDT 2
- YCBD 0
- Target Price
- HSDT $24.00
- YCBD N/A
- AVG Volume (30 Days)
- HSDT 116.7K
- YCBD 193.9K
- Earning Date
- HSDT 11-12-2024
- YCBD 12-20-2024
- Dividend Yield
- HSDT N/A
- YCBD N/A
- EPS Growth
- HSDT N/A
- YCBD N/A
- EPS
- HSDT N/A
- YCBD N/A
- Revenue
- HSDT $502,000.00
- YCBD $20,636,546.00
- Revenue This Year
- HSDT $16.41
- YCBD N/A
- Revenue Next Year
- HSDT $31.97
- YCBD $9.38
- P/E Ratio
- HSDT N/A
- YCBD N/A
- Revenue Growth
- HSDT N/A
- YCBD N/A
- 52 Week Low
- HSDT $0.37
- YCBD $0.42
- 52 Week High
- HSDT $9.50
- YCBD $1.73
- Technical
- Relative Strength Index (RSI)
- HSDT 39.76
- YCBD 46.39
- Support Level
- HSDT $0.44
- YCBD $0.42
- Resistance Level
- HSDT $0.58
- YCBD $0.52
- Average True Range (ATR)
- HSDT 0.06
- YCBD 0.05
- MACD
- HSDT 0.00
- YCBD -0.00
- Stochastic Oscillator
- HSDT 4.17
- YCBD 29.63
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.